techend
By Malik Shahzad Aslam :
Federal authorities in the United States have unsealed a major indictment against four individuals of Pakistani origin, accused of orchestrating a sprawling $41 million financial crime syndicate. The operation, which reportedly ran from 2020 to 2024, utilized a combination of high-level insider trading, corporate hacking, and sophisticated market manipulation to defraud the U.S. securities and crypto markets.
The Defendants: A Family-Led Syndicate
The case centers on the Shoukat brothers, who hold dual U.S.-Pakistani citizenship, along with a childhood associate. Each allegedly played a distinct role in the multi-continental scheme:
-
Muhammad Saad Shoukat (33): Described as the mastermind, he was a PhD student in Immunology who allegedly cultivated a source within a San Francisco investment bank to obtain confidential merger information.
-
Muhammad Arham Shoukat (35): The technical specialist. Operating out of Islamabad and Malaysia, he is accused of managing the hacking operations and creating fraudulent web infrastructure.
-
Muhammad Shahwaiz Shoukat (36): The money manager. Based in Amsterdam, he allegedly utilized various accounts—including those in his ex-wife’s name—to move and trade illicit funds.
-
Daniyal “Dan” Khan (33): A dual UK-Pakistani national and close associate who allegedly participated in the coordinated trading.
A Triple-Threat Fraud Strategy
The prosecution has categorized the group’s illegal activities into three primary methods of manipulation:
1. Exploiting Inside Information
By obtaining Material Non-Public Information (MNPI) regarding upcoming acquisitions, the group placed aggressive trades before the news hit the public. Major profits were linked to companies such as GBT Therapeutics and Oak Street Health.
2. Fabricating Medical Data
In a particularly deceptive move, the brothers allegedly compromised a breast cancer patient forum. They posted falsified clinical data regarding Olema Pharmaceuticals, creating a synthetic “hype” that inflated the stock price, allowing them to sell their positions at the peak.
3. Spoofing and Fake Press Releases
The group allegedly hired professional hackers to create a “spoof” website for Opiant Pharmaceuticals. By impersonating the company, they tricked a public relations firm into issuing a fake $225 million buyout announcement. The stock surged by 29% almost instantly, at which point the group liquidated their holdings.
About The Author
